Status:
COMPLETED
Intravenous Lidocaine in Open Lung Resection Surgery
Lead Sponsor:
Saint-Joseph University
Conditions:
Lidocaine
Pain, Postoperative
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
Management of postoperative pain in 2020 remains a challenge for anesthesiologists in the perioperative period. Lidocaine is an amide local anesthetic, it is one of the oldest adjuvant analgesics and ...
Eligibility Criteria
Inclusion
- American society of anesthesiologists (ASA) scores of I, II or III.
- Left or right posterolateral thoracotomy with postoperative monitoring in the intensive care unit (ICU) for at least 24 hours (h).
Exclusion
- patient's refusal to participate
- ASA score of IV or higher
- severe hepatic or renal insufficiency
- allergy to lidocaine, morphine or NSAIDs
- cardiac arrhythmias or
- epilepsy,
- delayed extubation for more than 2 h postoperatively
- urgent surgery
Key Trial Info
Start Date :
January 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04480281
Start Date
January 10 2020
End Date
May 15 2020
Last Update
July 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hotel Dieu de France
Beirut, Lebanon, 1104 2020